Perivascular administration of drugs and genes as a means of reducing vein graft failure

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 203-216

  Wiedemann, Dominik ^a   Kocher, Alfred ^a   Bonaros, Nikolaos ^b   Semsroth, Severin ^b   Laufer, Guenther ^a   Grimm, Michael ^b   Schachner, Thomas ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BOSENTAN; BSF 302146; CGS 24592; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; ENZYME INHIBITOR; FOLIC ACID; HEPARIN; LOSARTAN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PACLITAXEL; PROSTACYCLIN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; RHO KINASE; SPERMINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID; VERAPAMIL;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE ARREST; CELL PROLIFERATION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE MODEL; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VEIN GRAFT DISEASE; VEIN GRAFT FAILURE; VIRAL GENE THERAPY;

EID: 84861682903     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.02.012     Document Type: Review

References (122)

1. J. Tatoulis, B.F. Buxton, and J.A. Fuller Patencies of 2127 arterial to coronary conduits over 15 years Ann Thorac Surg 77 2004 93 101
2. T. Schachner, and L.G. Bonatti J. The role of vein grafts in coronary surgery Eur Surg 2 2007 72 75
3. G.T. Lau, H.C. Lowe, and L. Kritharides Cardiac saphenous vein bypass graft disease Semin Vasc Med 4 2004 153 159
4. D. Wiedemann, D. Bernhard, G. Laufer, and A. Kocher The elderly patient and cardiac surgery - a mini-review Gerontology 56 2010 241 249
5. S. Goldman, K. Zadina, T. Moritz, T. Ovitt, G. Sethi, J.G. Copeland, L. Thottapurathu, B. Krasnicka, N. Ellis, R.J. Anderson, and W. Henderson Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study J Am Coll Cardiol 44 2004 2149 2156
6. A.R. Halabi, J.H. Alexander, L.K. Shaw, T.J. Lorenz, L. Liao, D.F. Kong, C.A. Milano, R.A. Harrington, and P.K. Smith Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery Am J Cardiol 96 2005 1254 1259
7. P. Parang, and R. Arora Coronary vein graft disease: pathogenesis and prevention Can J Cardiol 25 2009 e57 e62
8. T. Schachner Pharmacologic inhibition of vein graft neointimal hyperplasia J Thorac Cardiovasc Surg 131 2006 1065 1072
9. L. Zhang, N.J. Freedman, L. Brian, and K. Peppel Graft-extrinsic cells predominate in vein graft arterialization Arterioscler Thromb Vasc Biol 24 2004 470 476
10. T. Schachner, G. Laufer, and J. Bonatti In vivo (animal) models of vein graft disease Eur J Cardiothorac Surg 30 2006 451 463
11. S. Wan, A.P. Yim, J.L. Johnson, N. Shukla, G.D. Angelini, F.C. Smith, M.R. Dashwood, and J.Y. Jeremy The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts J Thorac Cardiovasc Surg 127 2004 1317 1322
12. J. Bloor, N. Shukla, F.C. Smith, G.D. Angelini, and J.Y. Jeremy Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes Diabetologia 53 2010 980 988
13. A. Yuda, S. Takai, D. Jin, Y. Sawada, M. Nishimoto, N. Matsuyama, K. Asada, K. Kondo, S. Sasaki, and M. Miyazaki Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins Life Sci 68 2000 41 48
14. A. Chaux, X.M. Ruan, M.C. Fishbein, Y. Ouyang, S. Kaul, J.A. Pass, and J.M. Matloff Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation J Thorac Cardiovasc Surg 115 1998 604 612 (discussion 612-604)
15. J. Ge, D. Huang, C. Liang, Y. Luo, Q. Jia, and K. Wang Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan Atherosclerosis 177 2004 263 268
16. G.J. Fulton, L. Barber, E. Svendsen, P.O. Hagen, and M.G. Davies Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia J Surg Res 69 1997 128 134
17. T.T. Huynh, M.G. Davies, M.J. Trovato, L. Barber, H.J. Safi, and P.O. Hagen Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts J Surg Res 84 1999 223 232
18. B.H. Annex, M.G. Davies, G.J. Fulton, T.T. Huynh, K.M. Channon, M.D. Ezekowitz, and P.O. Hagen Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts J Surg Res 80 1998 164 170
19. R. Brauner, H. Laks, D.C. Drinkwater Jr., G. Chaudhuri, O. Shvarts, T. Drake, S. Bhuta, D. Mishaly, I. Fishbein, and G. Golomb Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts J Thorac Cardiovasc Surg 114 1997 53 63
20. E. Torsney, U. Mayr, Y. Zou, W.D. Thompson, Y. Hu, and Q. Xu Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection Circ Res 94 2004 1466 1473
21. T. Schachner, A. Oberhuber, Y. Zou, A. Tzankov, H. Ott, G. Laufer, and J. Bonatti Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts Eur J Cardiothorac Surg 27 2005 302 306
22. T. Schachner, Y. Zou, A. Oberhuber, A. Tzankov, T. Mairinger, G. Laufer, and J.O. Bonatti Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts Ann Thorac Surg 77 2004 1580 1585
23. T. Schachner, C. Steger, S. Heiss, N. Bonaros, W. Sterlacci, G. Laufer, and J. Bonatti Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins Eur J Cardiothorac Surg 32 2007 906 911
24. T. Schachner, S. Heiss, D. Zipponi, A. Tzankov, O. Bernecker, A. Kroell, G. Laufer, and J. Bonatti Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts Heart Surg Forum 9 2006 E515 E517
25. T. Schachner, Y. Zou, A. Oberhuber, T. Mairinger, A. Tzankov, G. Laufer, H. Ott, and J. Bonatti Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts Eur J Cardiothorac Surg 25 2004 585 590
26. U. Reisinger, S. Schwaiger, I. Zeller, B. Messner, R. Stigler, D. Wiedemann, T. Mayr, C. Seger, T. Schachner, and V.M. Dirsch Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts Cardiovasc Res 82 2009 542 549
27. C. Shi, A. Patel, D. Zhang, H. Wang, P. Carmeliet, G.L. Reed, M.E. Lee, E. Haber, and N.E. Sibinga Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis Circ Res 84 1999 883 890
28. A.Y. Kim, P.L. Walinsky, F.D. Kolodgie, C. Bian, J.L. Sperry, C.B. Deming, E.A. Peck, J.G. Shake, G.B. Ang, and R.H. Sohn Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure Circ Res 90 2002 205 212
29. K.M. Channon, G.J. Fulton, M.G. Davies, K.G. Peters, M.D. Ezekowitz, P.O. Hagen, and B.H. Annex Modulation of tissue factor protein expression in experimental venous bypass grafts Arterioscler Thromb Vasc Biol 17 1997 1313 1319
30. R.L. McCann, P.O. Hagen, and J.C. Fuchs Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts Ann Surg 191 1980 238 243
31. J.Y. Jeremy, M.B. Izzat, S.D. Birkett, D.M. Knight, A.J. Bryan, and G.D. Angelini Reduced prostacyclin and increased leukotriene B4 synthesis in porcine venous-arterial grafts Ann Thorac Surg 61 1996 143 148
32. J.Y. Jeremy, M.R. Dashwood, M. Timm, M.B. Izzat, D. Mehta, A.J. Bryan, and G.D. Angelini Nitric oxide synthase and adenylyl and guanylyl cyclase activity in porcine interposition vein grafts Ann Thorac Surg 63 1997 470 476
33. T. Onohara, K. Okadome, S. Yamamura, K. Komori, T. Ishii, T. Odashiro, and K. Sugimachi Impaired endothelial prostacyclin production of the canine vein graft in a poor distal runoff limb Surgery 113 1993 700 708
34. T. Onohara, K. Okadome, T. Ishii, S. Yamamura, K. Komori, and K. Sugimachi The reversibility of impaired prostacyclin production of the vein graft J Surg Res 55 1993 344 350
35. M.H. Kown, A. Yamaguchi, C.L. Jahncke, D. Miniati, S. Murata, J. Grunenfelder, M.L. Koransky, J.B. Rothbard, and R.C. Robbins l-Arginine polymers inhibit the development of vein graft neointimal hyperplasia J Thorac Cardiovasc Surg 121 2001 971 980
36. N. Shukla, G.D. Angelini, R. Ascione, S. Talpahewa, R. Capoun, and J.Y. Jeremy Nitric oxide donating aspirins: novel drugs for the treatment of saphenous vein graft failure Ann Thorac Surg 75 2003 1437 1442
37. D. Wiedemann, S. Schneeberger, P. Friedl, K. Zacharowski, N. Wick, F. Boesch, R. Margreiter, G. Laufer, P. Petzelbauer, and S. Semsroth The fibrin-derived peptide Bbeta(15-42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model Transplantation 89 2010 824 829
38. K.E. Porter, D.H. Olojugba, I. Masood, M. Pemberton, P.R. Bell, and N.J. London Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein J Vasc Surg 28 1998 695 701
39. K.E. Porter, T. Dickinson, and N.J. London Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition J Vasc Surg 34 2001 548 554
40. M.R. Dashwood, D. Mehta, M.B. Izzat, M. Timm, A.J. Bryan, G.D. Angelini, and J.Y. Jeremy Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts Atherosclerosis 137 1998 233 242
41. P.C. Saunders, G. Pintucci, C.S. Bizekis, R. Sharony, K.M. Hyman, F. Saponara, F.G. Baumann, E.A. Grossi, S.B. Colvin, P. Mignatti, and A.C. Galloway Vein graft arterialization causes differential activation of mitogen-activated protein kinases J Thorac Cardiovasc Surg 127 2004 1276 1284
42. A. Yamashita, A.K. Hanna, S. Hirata, A. Dardik, and B.E. Sumpio Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling J Vasc Surg 37 2003 866 873
43. M. Sugimoto, D. Yamanouchi, and K. Komori Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway Surg Today 39 2009 459 465
44. T. Leung, E. Manser, L. Tan, and L. Lim A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes J Biol Chem 270 1995 29051 29054
45. T. Ishizaki, M. Maekawa, K. Fujisawa, K. Okawa, A. Iwamatsu, A. Fujita, N. Watanabe, Y. Saito, A. Kakizuka, N. Morii, and S. Narumiya The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase EMBO J 15 1996 1885 1893
46. K. Kimura, M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, and K. Okawa Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science 273 1996 245 248
47. K. Kaibuchi, S. Kuroda, and M. Amano Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells Annu Rev Biochem 68 1999 459 486
48. K. Kaibuchi Regulation of cytoskeleton and cell adhesion by Rho targets Prog Mol Subcell Biol 22 1999 23 38
49. Y. Fukata, M. Amano, and K. Kaibuchi Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells Trends Pharmacol Sci 22 2001 32 39
50. K. Riento, and A.J. Ridley Rocks: multifunctional kinases in cell behaviour Nat Rev Mol Cell Biol 4 2003 446 456
51. M. Nakayama, M. Amano, A. Katsumi, T. Kaneko, S. Kawabata, M. Takefuji, and K. Kaibuchi Rho-kinase and myosin II activities are required for cell type and environment specific migration Genes Cells 10 2005 107 117
52. H. Shimokawa, and A. Takeshita Rho-kinase is an important therapeutic target in cardiovascular medicine Arterioscler Thromb Vasc Biol 25 2005 1767 1775
53. Y. Rikitake, and J.K. Liao ROCKs as therapeutic targets in cardiovascular diseases Expert Rev Cardiovasc Ther 3 2005 441 451
54. T. Furuyama, K. Komori, H. Shimokawa, Y. Matsumoto, T. Uwatoku, K. Hirano, and Y. Maehara Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits J Vasc Surg 43 2006 1249 1256
55. M. Kalra, and V.M. Miller Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow J Vasc Res 37 2000 576 584
56. M.G. Davies, G.J. Fulton, E. Svendsen, and P.O. Hagen Time course of the regression of intimal hyperplasia in experimental vein grafts Cardiovasc Pathol 8 1999 161 168
57. C.M. Aguilera, S.J. George, J.L. Johnson, and A.C. Newby Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein Cardiovasc Res 58 2003 679 688
58. A. Sokal, M. Zembala, A. Radomski, A. Kocher, J. Pacholewicz, J. Los, E. Jedrzejczyk, and M. Radomski A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery J Thorac Cardiovasc Surg 137 2009 1218 1224
59. K.M. Southgate, D. Mehta, M.B. Izzat, A.C. Newby, and G.D. Angelini Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts Arterioscler Thromb Vasc Biol 19 1999 1640 1649
60. K.E. Porter, I.M. Loftus, M. Peterson, P.R. Bell, N.J. London, and M.M. Thompson Marimastat inhibits neointimal thickening in a model of human vein graft stenosis Br J Surg 85 1998 1373 1377
61. K.E. Porter, M.M. Thompson, I.M. Loftus, E. McDermott, L. Jones, M. Crowther, P.R. Bell, and N.J. London Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis Eur J Vasc Endovasc Surg 17 1999 404 412
62. J.P. Werba, E. Tremoli, P. Massironi, M. Camera, A. Cannata, F. Alamanni, P. Biglioli, and A. Parolari Statins in coronary bypass surgery: rationale and clinical use Ann Thorac Surg 76 2003 2132 2140
63. K.E. Porter, J. Naik, N.A. Turner, T. Dickinson, M.M. Thompson, and N.J. London Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration J Vasc Surg 36 2002 150 157
64. M.N. el-Sanadiki, K.S. Cross, J.J. Murray, R.W. Schuman, E. Mikat, R.L. McCann, and P.O. Hagen Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment Ann Surg 212 1990 87 96
65. A. Daugherty, and L. Cassis Angiotensin II-mediated development of vascular diseases Trends Cardiovasc Med 14 2004 117 120
66. M.K. O'Donohoe, L.B. Schwartz, Z.S. Radic, E.M. Mikat, R.L. McCann, and P.O. Hagen Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts Ann Surg 214 1991 727 732
67. J.P. Tsikouris, J.A. Suarez, J.S. Simoni, M. Ziska, and G.E. Meyerrose Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction Coron Artery Dis 15 2004 211 217
68. K. Tsunemi, S. Takai, M. Nishimoto, A. Yuda, D. Jin, M. Sakaguchi, Y. Sawada, K. Asada, K. Kondo, S. Sasaki, and M. Miyazaki Lengthy suppression of vascular proliferation by a chymase inhibitor in dog grafted veins J Thorac Cardiovasc Surg 124 2002 621 625
69. G.J. Fulton, M.G. Davies, L. Barber, E. Svendsen, and P.O. Hagen Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809 Surgery 123 1998 218 227
70. R. Morishita, G.H. Gibbons, K.E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V.J. Dzau Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proc Natl Acad Sci USA 90 1993 8474 8478
71. S.J. Chen, Y.F. Chen, D.M. Miller, H. Li, and S. Oparil Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo Circulation 90 1994 2468 2473
72. H.E. von der Leyen, G.H. Gibbons, R. Morishita, N.P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J.P. Cooke, and V.J. Dzau Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene Proc Natl Acad Sci USA 92 1995 1137 1141
73. R. Morishita, G.H. Gibbons, M. Horiuchi, K.E. Ellison, M. Nakama, L. Zhang, Y. Kaneda, T. Ogihara, and V.J. Dzau A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 92 1995 5855 5859
74. M.J. Mann, G.H. Gibbons, R.S. Kernoff, F.P. Diet, P.S. Tsao, J.P. Cooke, Y. Kaneda, and V.J. Dzau Genetic engineering of vein grafts resistant to atherosclerosis Proc Natl Acad Sci USA 92 1995 4502 4506
75. M.J. Pollman, J.L. Hall, M.J. Mann, L. Zhang, and G.H. Gibbons Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease Nat Med 4 1998 222 227
76. S.J. George, C.T. Lloyd, G.D. Angelini, A.C. Newby, and A.H. Baker Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3 Circulation 101 2000 296 304
77. M.R. Kibbe, E. Tzeng, S.L. Gleixner, S.C. Watkins, I. Kovesdi, A. Lizonova, M.S. Makaroun, T.R. Billiar, and R.Y. Rhee Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia J Vasc Surg 34 2001 156 165
78. A. Ehsan, M.J. Mann, G. Dell'Acqua, and V.J. Dzau Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy J Thorac Cardiovasc Surg 121 2001 714 722
79. N. Ohno, H. Itoh, T. Ikeda, K. Ueyama, K. Yamahara, K. Doi, J. Yamashita, M. Inoue, K. Masatsugu, and N. Sawada Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide Circulation 105 2002 1623 1626
80. E.F. Akowuah, P.J. Sheridan, G.J. Cooper, and C. Newman Preventing saphenous vein graft failure: does gene therapy have a role? Ann Thorac Surg 76 2003 959 966
81. E.G. Nabel, G. Plautz, F.M. Boyce, J.C. Stanley, and G.J. Nabel Recombinant gene expression in vivo within endothelial cells of the arterial wall Science 244 1989 1342 1344
82. D.A. Dichek, R.F. Neville, J.A. Zwiebel, S.M. Freeman, M.B. Leon, and W.F. Anderson Seeding of intravascular stents with genetically engineered endothelial cells Circulation 80 1989 1347 1353
83. L. Campeau, M. Enjalbert, J. Lesperance, M.G. Bourassa, P. Kwiterovich Jr., S. Wacholder, and A. Sniderman The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery N Engl J Med 311 1984 1329 1332
84. M.G. Bourassa Fate of venous grafts: the past, the present and the future J Am Coll Cardiol 17 1991 1081 1083
85. G.M. Fitzgibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
86. S. Baek, and K.L. March Gene therapy for restenosis: getting nearer the heart of the matter Circ Res 82 1998 295 305
87. J.A. O'Brien, M. Holt, G. Whiteside, S.C. Lummis, and M.H. Hastings Modifications to the hand-held Gene Gun: improvements for in vitro biolistic transfection of organotypic neuronal tissue J Neurosci Methods 112 2001 57 64
88. M.L. Edelstein, M.R. Abedi, and J. Wixon Gene therapy clinical trials worldwide to 2007 - an update J Gene Med 9 2007 833 842
89. G. Leclerc, D. Gal, S. Takeshita, S. Nikol, L. Weir, and J.M. Isner Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries J Clin Invest 90 1992 936 944
90. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient and selective adenovirus-mediated gene transfer into vascular neointima Circulation 88 1993 2838 2848
91. A.H. Schulick, K.D. Newman, R. Virmani, and D.A. Dichek In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity Circulation 91 1995 2407 2414
92. K.D. Newman, P.F. Dunn, J.W. Owens, A.H. Schulick, R. Virmani, G. Sukhova, P. Libby, and D.A. Dichek Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia J Clin Invest 96 1995 2955 2965
93. A.H. Schulick, G. Vassalli, P.F. Dunn, G. Dong, J.J. Rade, C. Zamarron, and D.A. Dichek Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity J Clin Invest 99 1997 209 219
94. A. Lafont, G. Loirand, P. Pacaud, F. Vilde, P. Lemarchand, and D. Escande Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector Hum Gene Ther 8 1997 1033 1040
95. S. Lehrman Virus treatment questioned after gene therapy death Nature 401 1999 517 518
96. A. Lawrie, A.F. Brisken, S.E. Francis, D.I. Tayler, J. Chamberlain, D.C. Crossman, D.C. Cumberland, and C.M. Newman Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro Circulation 99 1999 2617 2620
97. C.M. Newman, A. Lawrie, A.F. Brisken, and D.C. Cumberland Ultrasound gene therapy: on the road from concept to reality Echocardiography 18 2001 339 347
98. Y. Taniyama, K. Tachibana, K. Hiraoka, M. Aoki, S. Yamamoto, K. Matsumoto, T. Nakamura, T. Ogihara, Y. Kaneda, and R. Morishita Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle Gene Ther 9 2002 372 380
99. Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya, M. Aoki, T. Ogihara, K. Yasufumi, and R. Morishita Local delivery of plasmid DNA into rat carotid artery using ultrasound Circulation 105 2002 1233 1239
100. M.J. Mann, G.H. Gibbons, P.S. Tsao, H.E. von der Leyen, J.P. Cooke, R. Buitrago, R. Kernoff, and V.J. Dzau Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts J Clin Invest 99 1997 1295 1301
101. Z. Yang, R.D. Simari, F. Tanner, D. Stephan, G.J. Nabel, and E.G. Nabel Gene transfer approaches to the regulation of vascular cell proliferation Semin Interv Cardiol 1 1996 181 184
102. R.D. Simari, H. San, M. Rekhter, T. Ohno, D. Gordon, G.J. Nabel, and E.G. Nabel Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries J Clin Invest 98 1996 225 235
103. M. Wilbring, S.M. Tugtekin, B. Zatschler, A. Ebner, H. Reichenspurner, K. Matschke, and A. Deussen Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts Eur J Cardiothorac Surg 40 2011 811 815
104. C.M. Holt, S.E. Francis, A.C. Newby, S. Rogers, P.A. Gadsdon, T. Taylor, and G.D. Angelini Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery Ann Thorac Surg 55 1993 1522 1528
105. D.G. Cable, T. O'Brien, H.V. Schaff, and V.J. Pompili Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits Circulation 96 1997 II-173-178
106. D.G. Cable, J.A. Caccitolo, N. Caplice, T. O'Brien, R.D. Simari, R.C. Daly, J.A. Dearani, C.J. Mullany, T.A. Orszulak, and H.V. Schaff The role of gene therapy for intimal hyperplasia of bypass grafts Circulation 100 1999 II392 II396
107. Y. Shi, M. Pieniek, A. Fard, J. O'Brien, J.D. Mannion, and A. Zalewski Adventitial remodeling after coronary arterial injury Circulation 93 1996 340 348
108. M.P. Bendeck, C. Irvin, and M.A. Reidy Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury Circ Res 78 1996 38 43
109. S.J. George, J.L. Johnson, G.D. Angelini, A.C. Newby, and A.H. Baker Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein Hum Gene Ther 9 1998 867 877
110. M.J. Mann, A.D. Whittemore, M.C. Donaldson, M. Belkin, M.S. Conte, J.F. Polak, E.J. Orav, A. Ehsan, G. Dell'Acqua, and V.J. Dzau Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498
111. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr., T.J. Lorenz, A. Goyal, M. Gibson, M.J. Mack, and D. Gennevois Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
112. T. Matsumoto, K. Komori, Y. Yonemitsu, R. Morishita, K. Sueishi, Y. Kaneda, and K. Sugimachi Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff J Vasc Surg 27 1998 135 144
113. M.G. Davies, T.T. Huynh, G.J. Fulton, R.J. Lefkowitz, E. Svendsen, P.O. Hagen, and W.J. Koch G protein signaling and vein graft intimal hyperplasia: reduction of intimal hyperplasia in vein grafts by a Gbetagamma inhibitor suggests a major role of G protein signaling in lesion development Arterioscler Thromb Vasc Biol 18 1998 1275 1280
114. T.T. Huynh, G. Iaccarino, M.G. Davies, E. Svendsen, W.J. Koch, and P.O. Hagen Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts Surgery 124 1998 177 186
115. S.B. O'Blenes, S.H. Zaidi, A.Y. Cheah, B. McIntyre, Y. Kaneda, and M. Rabinovitch Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration Circulation 102 2000 III289 III295
116. K. Peppel, L. Zhang, T.T. Huynh, X. Huang, A. Jacobson, L. Brian, S.T. Exum, P.O. Hagen, and N.J. Freedman Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells reduces neointimal hyperplasia J Mol Cell Cardiol 34 2002 1399 1409
117. Y. Hu, A.H. Baker, Y. Zou, A.C. Newby, and Q. Xu Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model Arterioscler Thromb Vasc Biol 21 2001 1275 1280
118. J.D. Mannion, M.L. Ormont, Y. Shi, J.E. O'Brien Jr., W. Chung, F. Roque, and A. Zalewski Saphenous vein graft protection: effects of c-myc antisense J Thorac Cardiovasc Surg 115 1998 152 161
119. T. Shintani, Y. Sawa, T. Takahashi, G. Matsumiya, N. Matsuura, Y. Miyamoto, and H. Matsuda Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia Ann Thorac Surg 74 2002 1132 1137 (discussion 1137-1138)
120. P. Zilla, P. Human, M. Wolf, W. Lichtenberg, N. Rafiee, D. Bezuidenhout, N. Samodien, C. Schmidt, and T. Franz Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates J Thorac Cardiovasc Surg 136 2008 717 725
121. J. Schoettler, J. Jussli-Melchers, C. Grothusen, L. Stracke, F. Schoeneich, S. Stohn, G. Hoffmann, and J. Cremer Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively Interact Cardiovasc Thorac Surg 13 2011 396 400
122. V. Parsonnet, A.A. Lari, and I.H. Shah New stent for support of veins in arterial grafts Arch Surg 87 1963 696 702